Business Growth Program for Central Asia
A platform to accelerate commercial expansion
Central Asia is becoming an increasingly attractive destination for European product companies. Rising consumer demand, modern distribution channels and growing interest in high-quality products create substantial opportunities for manufacturers, exporters and distributors.
ACIR Southern Europe promotes a structured business growth program that enables companies to enter and scale in the region faster, with lower risk and a proven operational framework.
Key tools for efficient growth
The program includes:
- Financial instruments for import and export transactions.
- Improved market entry conditions.
- Direct access to European producers and exporters.
- Logistics optimization and regional warehousing.
- Marketing and commercial positioning.
ACIR Southern Europe acts as a business platform connecting European companies with buyers, distributors and investors in Central Asia, transforming market opportunities into long-term commercial success.
Subscribe to our newsletter
Read also
-
Economic diplomacy: a strategic bridge for business in Central Asia
Cooperation between ACIR Southern Europe and European embassies strengthens trade and investment opportunities across Central Asia.
29/06/2026 Read more -
More than a commercial representative office
The ACIR Southern Europe project office in Kazakhstan provides comprehensive support for international business development.
03/06/2026 Read more -
Trade fairs as a gateway to Central Asia
Trade fairs as a gateway to Central Asia ACIR Southern Europe 18/05/2026 International trade fairs and exhibitions remain one of the most effective ways to position companies, identify new business partners and strengthen relationships with existing clients. While digital communication has simplified initial contacts, face-to-face meetings continue to be essential for building trust, presenting products
18/05/2026 Read more -
ACIR expands pharmaceutical integration in Central Asia
ACIR Southern Europe strengthens its pharmaceutical presence in Central Asia through strategic institutional partnerships.
11/05/2026 Read more